Could your environment trigger this rare muscle disease?
NCT ID NCT01276470
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study investigates whether certain environmental exposures—like infections, stress, or sun exposure—are more common in people with anti-synthetase syndrome, a rare autoimmune condition that causes muscle weakness and lung disease. Researchers will compare 580 participants, including myositis patients with and without the syndrome, and healthy volunteers. Participants complete questionnaires and provide blood, urine, and house dust samples to identify potential triggers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify environmental triggers for anti-synthetase syndrome, potentially guiding future prevention strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find clear links, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATOMYOSITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
COMPLETEDBoston, Massachusetts, 02115, United States
-
Johns Hopkins University
COMPLETEDBaltimore, Maryland, 21205, United States
-
Mayo Clinic, Rochester
COMPLETEDRochester, Minnesota, 55905, United States
-
Mid-Atlantic Kaiser Permanente
COMPLETEDRockville, Maryland, 20853, United States
-
NIEHS Clinical Research Unit (CRU)
RECRUITINGResearch Triangle Park, North Carolina, 27709, United States
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
-
University of Miami Hospital
WITHDRAWNMiami, Florida, 33101, United States
-
University of Pittsburgh
COMPLETEDPittsburgh, Pennsylvania, 15261, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted immune drug calm rare muscle inflammation?
- Could a simple injection dissolve painful calcium lumps in rare diseases?
- HIV drug repurposed to fight muscle inflammation
- Can a skin biopsy tell your doctor which treatment will work?
- New hope for rare muscle disease: baricitinib trial aims to cut steroid use
- Scientists probe hidden clot risks in autoimmune skin disorders